Analysts Set Aspen Aerogels, Inc. (NYSE:ASPN) PT at $4.25

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have received a consensus rating of “Hold” from the seven brokerages that are presently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price objective among analysts that have covered the stock in the last year is $4.25.

A number of equities analysts have recently issued reports on the company. TD Cowen dropped their target price on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Barclays decreased their price target on Aspen Aerogels from $4.00 to $3.00 and set an “underweight” rating on the stock in a research note on Thursday, March 5th. Roth Mkm dropped their price objective on Aspen Aerogels from $6.00 to $3.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Zacks Research raised Aspen Aerogels from a “strong sell” rating to a “hold” rating in a report on Thursday, January 15th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, December 29th.

Hedge Funds Weigh In On Aspen Aerogels

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Raymond James Financial Inc. grew its stake in Aspen Aerogels by 6.8% during the second quarter. Raymond James Financial Inc. now owns 26,559 shares of the construction company’s stock worth $157,000 after buying an additional 1,687 shares during the last quarter. Legal & General Group Plc raised its stake in shares of Aspen Aerogels by 3.6% in the second quarter. Legal & General Group Plc now owns 67,130 shares of the construction company’s stock valued at $397,000 after acquiring an additional 2,324 shares during the last quarter. Osaic Holdings Inc. raised its stake in shares of Aspen Aerogels by 29.1% in the second quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company’s stock valued at $63,000 after acquiring an additional 2,390 shares during the last quarter. The Manufacturers Life Insurance Company boosted its holdings in shares of Aspen Aerogels by 12.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 24,671 shares of the construction company’s stock worth $146,000 after acquiring an additional 2,656 shares in the last quarter. Finally, Deutsche Bank AG boosted its holdings in shares of Aspen Aerogels by 1.3% in the 4th quarter. Deutsche Bank AG now owns 223,093 shares of the construction company’s stock worth $631,000 after acquiring an additional 2,880 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Trading Up 6.7%

Shares of ASPN stock opened at $3.27 on Friday. Aspen Aerogels has a 52-week low of $2.30 and a 52-week high of $9.78. The stock has a market cap of $270.44 million, a price-to-earnings ratio of -0.69 and a beta of 2.99. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.29 and a current ratio of 3.90. The firm has a fifty day moving average of $3.40 and a 200-day moving average of $4.61.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Wednesday, February 25th. The construction company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.07). The business had revenue of $41.34 million for the quarter, compared to analyst estimates of $44.25 million. Aspen Aerogels had a negative net margin of 143.69% and a negative return on equity of 13.91%. Aspen Aerogels’s revenue was down 66.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.14 earnings per share. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. On average, equities research analysts forecast that Aspen Aerogels will post 0.17 earnings per share for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.